Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wittkowski

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Gut|January 13, 2009
Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damageD Foell, H Wittkowski, J Roth
Zeitschrift Fur Rheumatologie|February 4, 2017
[Role of genetics in familial Mediterranean fever]T Kallinich, B Orak, H Wittkowski
Zeitschrift Fur Rheumatologie|April 8, 2020
[Still's disease as biphasic disorder : Current knowledge on pathogenesis and novel treatment approaches]D Föll, H Wittkowski, C Hinze
Zeitschrift Fur Rheumatologie|May 13, 2020
[Classification of autoinflammatory diseases based on pathophysiological mechanisms]T Kallinich, C Hinze, H Wittkowski
Acta Endocrinologica|April 1, 1992
The pars tuberalis of the hypophysis: a modulator of the pars distalis?W H Wittkowski, A H Schulze-Bonhage, T M Böckers
Pneumologie (Stuttgart, Germany)|February 14, 2019
[Primary Immunodeficiency: Primary Antibody Disorders in Respiratory Medicine]G Evers, M Thrull, H Wittkowski, et al.
Zeitschrift Fur Rheumatologie|April 22, 2021
[Cushing's syndrome with subsequent tertiary adrenocortical insufficiency after simultaneous multiple intra-articular local glucocorticoid treatment : Keep an eye on hormone deficiency conditions requiring treatment after multiple administrations of local steroids]A Schramm, D Windschall, C Hinze, et al.
Allergy|May 16, 2012
Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label studyK Krause, K Weller, R Stefaniak, et al.
Gut|August 7, 2007
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndromeT Kaiser, J Langhorst, H Wittkowski, et al.
Zeitschrift Fur Rheumatologie|January 27, 2019
[Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology]T Kallinich, N Blank, T Braun, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Gut|January 13, 2009
Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damageD Foell, H Wittkowski, J Roth
Zeitschrift Fur Rheumatologie|February 4, 2017
[Role of genetics in familial Mediterranean fever]T Kallinich, B Orak, H Wittkowski
Zeitschrift Fur Rheumatologie|April 8, 2020
[Still's disease as biphasic disorder : Current knowledge on pathogenesis and novel treatment approaches]D Föll, H Wittkowski, C Hinze
Zeitschrift Fur Rheumatologie|May 13, 2020
[Classification of autoinflammatory diseases based on pathophysiological mechanisms]T Kallinich, C Hinze, H Wittkowski
Acta Endocrinologica|April 1, 1992
The pars tuberalis of the hypophysis: a modulator of the pars distalis?W H Wittkowski, A H Schulze-Bonhage, T M Böckers
Pneumologie (Stuttgart, Germany)|February 14, 2019
[Primary Immunodeficiency: Primary Antibody Disorders in Respiratory Medicine]G Evers, M Thrull, H Wittkowski, et al.
Zeitschrift Fur Rheumatologie|April 22, 2021
[Cushing's syndrome with subsequent tertiary adrenocortical insufficiency after simultaneous multiple intra-articular local glucocorticoid treatment : Keep an eye on hormone deficiency conditions requiring treatment after multiple administrations of local steroids]A Schramm, D Windschall, C Hinze, et al.
Allergy|May 16, 2012
Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label studyK Krause, K Weller, R Stefaniak, et al.
Gut|August 7, 2007
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndromeT Kaiser, J Langhorst, H Wittkowski, et al.
Zeitschrift Fur Rheumatologie|January 27, 2019
[Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology]T Kallinich, N Blank, T Braun, et al.
Pageof 2